SEC Form 4 · accession 0001232524-15-000130
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Suzanne Sawochka Hooper
Officer — EVP & General Counsel
Period of report
Jul 14, 2015
Accepted (ET)
Jul 16, 2015 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 14, 2015 | M | 4,000 | $46.83 | A | 50,420 | D | |
| Ordinary Shares | Jul 14, 2015 | S | 4,000 | $177.79 | D | 46,420 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $46.83 | Jul 14, 2015 | M | 4,000 | D | — | Aug 8, 2022 | Ordinary Shares | 4,000 | 38,632 | D |
Explanation of responses
- F1The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2As of the date of this report, the remaining ordinary shares subject to this option are vested with respect to 22,697 shares and will vest with respect to 6,403 shares in equal monthly installments from August 9, 2015 to December 9, 2015 and with respect to 9,532 shares in equal monthly installments from January 9, 2016 to August 9, 2016.